Banner
The Scorched Cherry Twig And Other Christmas Miracles Get A Science Look

Bleeding hosts and stigmatizations are the best-known medieval miracles but less known ones, like ...

$0.50 Pantoprazole For Stomach Bleeding In ICU Patients Could Save Families Thousands Of Dollars

The inexpensive medication pantoprazole prevents potentially serious stomach bleeding in critically...

Metformin Diabetes Drug Used Off-Label Also Reduces Irregular Heartbeats

Adults with atrial fibrillation (AFib) who are not diabetic but are overweight and took the diabetes...

Your Predator: Badlands Future - Optical Camouflage, Now Made By Bacteria

In the various 'Predator' films, the alien hunter can see across various spectra while enabling...

User picture.
News StaffRSS Feed of this column.

News Releases From All Over The World, Right To You... Read More »

Blogroll

Women who understand the risk of over-detection and over-diagnosis associated with mammography screening have lower intentions to have a breast screening test, according to a new study. Over-detection and over-diagnosis refers to the diagnosis and treatment of breast cancer that would not have presented clinically during a woman's lifetime.

Such a diagnosis, and the resulting overtreatment, can harm women physically and emotionally.

A new family of bacteria that are common in malaria mosquitoes has been described by researchers at Swedish University of Agricultural Sciences (SLU) and Uppsala University in Sweden, Justus-Liebig-Universität Giessen, Germany, and the Veterinärmedizinische Universität, Austria. Now, attempts are made to use these bacteria in the fight against malaria.

Ovarian cancer is the deadliest of all cancers affecting the female reproductive system with very few effective treatments available. Prognosis is even worse among patients with certain subtypes of the disease. Now, researchers at The Wistar Institute have identified a new therapeutic target in a particularly aggressive form of ovarian cancer, paving the way for what could be the first effective targeted therapy of its kind for the disease.

The findings were published online by the journal Nature Medicine.

Frequent menopausal vasomotor symptoms (VMS), including hot flashes and night sweats, lasted for more than seven years during the transition to menopause for more than half of the women in a large study and African American women reported the longest total VMS duration, according to a new study.

VMS are the hallmark of the menopausal transition and they can affect the quality of women's lives. Up to 80 percent of women experience VMS during the transition to menopause and, despite the pervasiveness of these symptoms, robust estimates about how long VMS last are lacking.

Picture this: For the past two weeks you have felt continuously dejected. You have lost interest in what normally makes you happy. Perhaps you’ve slept poorly or lost your appetite. There is a risk that you have one of the most common maladies in the world: Depression.

You decide to see a doctor. She considers different treatments and finally she gives you a prescription for a small box of antidepressants. Whether they will help you is unclear. Some patients report an effect after two or three weeks, others don’t notice any change at all. Some even get even more depressed.

More depressed? If it is actually a healthy person who doesn't have clinical depression, it's certainly possible. 

Measurements at BESSY II have shown how spin filters forming within magnetic sandwiches influence tunnel magnetoresistance - results that can help in designing spintronic components. In doing so, the teams enhanced our understanding of processes that are important for future TMR data storage devices and other spintronic components.